Westpac Banking Corp (ASX:WBC) has named Nathan Goonan as its new Chief Financial Officer, replacing Michael Rowland. Goonan, currently Group CFO at National Australia Bank (OTC:NABZY) (NAB.AX), will assume the role later this year, the bank announced Monday.
With over 20 years in financial services, Goonan has held key leadership roles at NAB, overseeing finance, strategy, and mergers & acquisitions. Before becoming CFO, he served as NAB’s Group Executive for Strategy & Innovation, shaping the bank’s long-term growth initiatives.
NAB confirmed Goonan’s departure in a separate filing, appointing Shaun Dooley as interim CFO while searching for a permanent replacement.
Following the announcement, Westpac shares gained 0.7%, while NAB stock dipped 0.6% as of 00:34 GMT.
This leadership change marks a strategic shift for Westpac, as Goonan’s experience in financial planning and acquisitions could play a key role in the bank’s future direction. Investors will closely watch how he steers Westpac’s financial strategy amid evolving market conditions.


Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
First Western Ship Transits Strait of Hormuz Since Iran War Began
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Apple Turns 50: From Garage Startup to AI Crossroads
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



